Literature DB >> 8727323

Purification, stabilization, and crystallization of a modular protein: Grb2.

J P Guilloteau1, N Fromage, M Ries-Kautt, S Reboul, D Bocquet, H Dubois, D Faucher, C Colonna, A Ducruix, J Becquart.   

Abstract

We report here the purification and the crystallization of the modular protein Grb2. The protein was expressed as a fusion with glutathione-S-transferase and purified by affinity chromatography on glutathione agarose. It was apparent from reverse phase chromatography that the purified protein was conformationally unstable. Instability was overcome by the addition of 100 mM arginine to the buffers. Because Grb2 appeared to be extremely sensitive to oxidation, crystallization experiments were performed with a dialysis button technique involving daily addition of fresh DTT to the reservoirs. The presence of 8 to 14% glycerol was necessary to obtain monocrystals. These results are discussed in relation with the modular nature of Grb2.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8727323     DOI: 10.1002/(SICI)1097-0134(199605)25:1<112::AID-PROT9>3.0.CO;2-L

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  3 in total

1.  Regions outside of conserved PxxPxR motifs drive the high affinity interaction of GRB2 with SH3 domain ligands.

Authors:  Rebekah R Bartelt; Jonathan Light; Aldo Vacaflores; Alayna Butcher; Madhana Pandian; Piers Nash; Jon C D Houtman
Journal:  Biochim Biophys Acta       Date:  2015-06-12

2.  Structural basis for activation of ZAP-70 by phosphorylation of the SH2-kinase linker.

Authors:  Qingrong Yan; Tiago Barros; Patrick R Visperas; Sebastian Deindl; Theresa A Kadlecek; Arthur Weiss; John Kuriyan
Journal:  Mol Cell Biol       Date:  2013-03-25       Impact factor: 4.272

3.  The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells.

Authors:  Rosamaria Lappano; Christophe Mallet; Bruno Rizzuti; Fedora Grande; Giulia Raffaella Galli; Cillian Byrne; Isabelle Broutin; Ludivine Boudieu; Alain Eschalier; Yves Jacquot; Marcello Maggiolini
Journal:  Cells       Date:  2019-06-14       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.